Diclofenac Potassium
Rank #474 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$15.2M
Total Cost
96,736
Total Claims
$15.2M
Total Cost
2,621
Prescribers
$157
Cost per Claim
37,090
Beneficiaries
104,170
30-Day Fills
$5,800
Avg Cost/Provider
37
Avg Claims/Provider
Share of Medicare Part D Spending
0.01%
of total Medicare Part D spending
$15.2M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $15.2M total
Top Prescribers of Diclofenac Potassium
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Haleh Nassiri | Podiatry | New Hyde Park, NY | 93 | $630K |
| 2 | Hossam Amin | Pulmonary Disease | Brooklyn, NY | 123 | $470K |
| 3 | Vlad Nusinovich | Internal Medicine | West Hollywood, CA | 239 | $430K |
| 4 | Annmarie Moreno | Physician Assistant | Lancaster, CA | 85 | $317K |
| 5 | Frantz Fils Saint-Louis | Family Practice | Brooklyn, NY | 59 | $297K |
| 6 | Hadi Dourra | Internal Medicine | Redford, MI | 98 | $289K |
| 7 | Grant Williams | Interventional Pain Management | Beverly Hills, CA | 91 | $271K |
| 8 | Sanjay Godhwani | Rheumatology | Wading River, NY | 33 | $248K |
| 9 | Arthur Karaguezian | Family Practice | Northridge, CA | 57 | $226K |
| 10 | Lev Aminov | Internal Medicine | Flushing, NY | 129 | $213K |
| 11 | Gregory Smith | Interventional Pain Management | Fresno, CA | 52 | $208K |
| 12 | Gloria Monsalve | Family Practice | San Fernando, CA | 14 | $203K |
| 13 | Haleh Nassiri | Podiatry | New Hyde Park, NY | 65 | $201K |
| 14 | Harry Lifschutz | General Surgery | Indio, CA | 102 | $198K |
| 15 | Amr Nayel | Family Practice | Astoria, NY | 69 | $180K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 471 | Avatrombopag Maleate (Doptelet) | $15.4M | 1,156 |
| 472 | Primidone (Primidone) | $15.3M | 450,535 |
| 473 | Fluocinonide (Fluocinonide) | $15.3M | 217,528 |
| 474 | Diclofenac Potassium (Diclofenac Potassium) | $15.2M | 96,736 |
| 475 | Capmatinib Hydrochloride (Tabrecta) | $15.1M | 824 |
| 476 | Berotralstat Hydrochloride (Orladeyo) | $15.1M | 374 |
| 477 | Lansoprazole (Lansoprazole) | $15.0M | 309,355 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology